BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1081665)

  • 21. Immunological follow-up of acute lymphoblastic leukaemia.
    Krepler P; Pawlowsky J; Kummer M; Brunner R; Eibl M; Pawlowsky G
    Haematologia (Budap); 1976; 10(1):11-22. PubMed ID: 1070465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute lymphatic leukaemia in children: re-examination after remission of at least five years (author's transl)].
    Resch R; Haas H; Michlmayr G
    Dtsch Med Wochenschr; 1979 Jul; 104(29):1037-41. PubMed ID: 288556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [T and B-lymphocytes in acute lymphoblastic leukemia of childhood at diagnosis and during the initial stages of therapy (author's transl)].
    De Martino M; Biagioli EC; Pisanu C; Lippi A; Novembre E; Guazzelli C; Vierucci A
    Haematologica; 1979 Aug; 64(4):442-54. PubMed ID: 121579
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.
    Baccarani M; Gobbi M; Tura S
    N Engl J Med; 1980 Jan; 302(2):123. PubMed ID: 6965316
    [No Abstract]   [Full Text] [Related]  

  • 25. [Observation of surface markers of leukemic cells in three cases of chronic lymphatic leukemia (author's transl)].
    Park K; Kamitani T; Tatsumi Y; Im T; Tatsumi N; Kimura Y; Mahda H; Okuda K; Yamamoto S
    Rinsho Ketsueki; 1982 Jan; 23(1):91-9. PubMed ID: 6980302
    [No Abstract]   [Full Text] [Related]  

  • 26. An attempt to characterize lymphocytes of acute lymphoid leukaemia as T or B cells.
    Governa M; Massimo L; Rosanda C; Franchini MI; Tonda GP
    Biomedicine; 1973 Sep; 19(9):384-7. PubMed ID: 4600231
    [No Abstract]   [Full Text] [Related]  

  • 27. [Method for the characterization of peripheral lymphocytes in humans and their significance].
    Magrì D; Spadacenta F; Tritto MC
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):102-7. PubMed ID: 6969080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy].
    Kaftański R
    Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surface markers of T and B lymphocytes: I. General view and acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Nov; 102(11):643-6. PubMed ID: 7024694
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of natural killer cell defects in childhood acute lymphoblastic leukemia.
    Yamada S; Miyagawa Y; Komiyama A; Akabane T
    Jpn J Clin Oncol; 1984 Mar; 14(1):75-80. PubMed ID: 6608609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on the reactivity of T-lymphocytes in chronic lymphoid leukemia].
    Hunyadi J; Dobozy A; Husz S; Kenderessy AS; Krizsa F
    Z Hautkr; 1976 May; 51(09):367-70. PubMed ID: 1085541
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence of lymphocytes bearing both sheep erythrocyte and complement receptors during initial treatment of acute leukemia in children (author's transl)].
    Kuribayashi T; Tomidokoro R; Suzuki S; Kuroume T
    Rinsho Ketsueki; 1979 Apr; 20(4):381-7. PubMed ID: 312955
    [No Abstract]   [Full Text] [Related]  

  • 34. [Characteristics of acute lymphoblastic leukemia of children with 0-cells in the bone marrow and a predominance of T- or B-cells in the peripheral blood].
    Lenskaia RV; Samochatova EV; Rumiantsev AG; Izotova TA
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):20-4. PubMed ID: 6974356
    [No Abstract]   [Full Text] [Related]  

  • 35. [The T or B nature of neoplastic cells in lymphotic leukemia].
    Belpomme D; Dant Chev D; Du Rusquec E; Grandjon D; Huchet R; Pinon F; Pouillart P; Schwarzenberg L; Amiel JL; Mathé G
    Bull Cancer; 1974; 61(3):387-402. PubMed ID: 4618783
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequestration of PHA-responsive cells (T-lymphocytes) in the bone marrow of leukemic children undergoing long-term immunosuppressive therapy.
    Borella L; Green AA
    J Immunol; 1972 Nov; 109(5):927-32. PubMed ID: 4538718
    [No Abstract]   [Full Text] [Related]  

  • 37. [The significance of "T" and "B" markers on peripheral blood lymphocytes by leukemias (author's transl)].
    Handl S; Gabrilovac J; Milić N; Boranić M; Veselić B; Bauer Z; Koprcina M
    Lijec Vjesn; 1978 Jan; 100(1):11-6. PubMed ID: 306016
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunologic cell markers in acute lymphoblastic leukemia in children].
    Grigor'iants LIa
    Eksp Onkol; 1987; 9(2):28-30. PubMed ID: 3495426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Factors influencing outcome in children with acute lymphoblastic leukemia (author's transl)].
    Javier G; Ortega JJ; Domingo A; Sáenz A; Tusell J
    An Esp Pediatr; 1976 Jun; 9(4 Suppl):35-40. PubMed ID: 1066068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase and inhibition of pre-B cell proliferation in culture, by T cells.
    Paolucci P; Layward L; Hayward AR; Rapson NT; Soothill JF
    Clin Exp Immunol; 1981 Feb; 43(2):336-41. PubMed ID: 6974068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.